Keep Up With the Latest on COVID-19 Monoclonal Antibodies

April 2021

Bamlanivimab/etesevimab will be the third monoclonal antibody option authorized to treat COVID-19.

This combo joins bamlanivimab and casirivimab/imdevimab as another single-dose IV infusion. And more are in the works.

Recall that these "mabs" block SARS-CoV-2 from entering cells.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Measurement Hone Your Liquid-Measuring Skills
COVID-19 Expect New Questions About COVID-19 Vaccines
Med Safety Avoid Measurement Abbreviation Mishaps
COVID-19 Keep Up With the Latest on COVID-19 Monoclonal Antibodies
Injectables Prevent Large-Volume IV Mix-Ups
New Drugs Think of Remimazolam as Similar to Midazolam
COVID-19 Identify Outpatient COVID-19 Treatments During Med Histories
Mental Health Use Strategies to Combat Pandemic Fatigue
Heart Failure Verquvo Will Be a New Med to Treat Worsening Heart Failure